Twist Bioscience Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | +18.7% | +14.1% | +6.7% | +9.3% | +46.0% | +69.4% | +77.5% | +7.2% | -20.9% | |
| – | +120.7% | +56.6% | +277.2% | +53.1% | +116.4% | +115.3% | -62.0% | +68.2% | +26.6% | |
| – | +218.4% | +7.8% | +255.9% | +48.8% | +115.1% | +121.9% | – | – | – | |
| – | -153.8% | – | – | -940.3% | – | – | – | – | -181.8% | |
| – | +5.9% | -44.1% | +300.1% | -33.1% | +174.2% | +276.4% | -72.7% | -81.7% | +451.7% | |
| – | -70.4% | – | -490.0% | +9.4% | – | -249.2% | – | -106.1% | +706.3% | |
| – | +5.4% | +38.6% | +76.7% | -101.5% | +348.1% | -28.5% | -43.2% | -9.8% | -99.6% | |
| – | -127.7% | +25.1% | +0.0% | +33.3% | +0.0% | -53.3% | -100.0% | – | – | |
| – | -8.4% | +39.2% | +78.5% | +91.5% | +8.4% | -17.8% | -99.7% | +656.3% | +314.2% | |
| – | – | +1,782.6% | -168.9% | – | +696.4% | -123.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.